SIRPB1
Signal-regulatory protein beta-1
Also known as: CD172b, SIRB1_HUMAN, SIRP-BETA-1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O00241
- Gene
- SIRPB1
- Ensembl
- ENSG00000101307
- Chromosome
- 20
- Canonical length
- 398 aa
- Protein class
- CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Vesicles,Centrosome
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene is a member of the signal-regulatory-protein (SIRP) family, and also belongs to the immunoglobulin superfamily. SIRP family members are receptor-type transmembrane glycoproteins known to be involved in the negative regulation of receptor tyrosine kinase-coupled signaling processes. This protein was found to interact with TYROBP/DAP12, a protein bearing immunoreceptor tyrosine-based activation motifs. This protein was also reported to participate in the recruitment of tyrosine kinase SYK. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2009]
Canonical amino-acid sequenceUniProt
398 residues, UniProt reviewed canonical sequence.
>O00241|SIRPB1
1 MPVPASWPHL PSPFLLMTLL LGRLTGVAGE DELQVIQPEK SVSVAAGESA TLRCAMTSLI
61 PVGPIMWFRG AGAGRELIYN QKEGHFPRVT TVSELTKRNN LDFSISISNI TPADAGTYYC
121 VKFRKGSPDD VEFKSGAGTE LSVRAKPSAP VVSGPAVRAT PEHTVSFTCE SHGFSPRDIT
181 LKWFKNGNEL SDFQTNVDPA GDSVSYSIHS TARVVLTRGD VHSQVICEIA HITLQGDPLR
241 GTANLSEAIR VPPTLEVTQQ PMRAENQANV TCQVSNFYPR GLQLTWLENG NVSRTETAST
301 LIENKDGTYN WMSWLLVNTC AHRDDVVLTC QVEHDGQQAV SKSYALEISA HQKEHGSDIT
361 HEAALAPTAP LLVALLLGPK LLLVVGVSAI YICWKQKALocalizationUniProt · AlphaFold · HPA
Whether an antibody against SIRPB1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 49 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 49 nTPM
- appendix: 27 nTPM
- spleen: 25 nTPM
- lung: 18 nTPM
- gallbladder: 11 nTPM
- lymph node: 10 nTPM
Single-cell type
- neutrophils: 11 nCPM
- neutrophil progenitors: 3.9 nCPM
- monocytes: 2.3 nCPM
- pdcs: 1.3 nCPM
- kupffer cells: 1 nCPM
- monocyte progenitors: 0.9 nCPM
Immune cell
- neutrophil: 1,606 nTPM
- eosinophil: 872 nTPM
- classical monocyte: 504 nTPM
- intermediate monocyte: 421 nTPM
- non-classical monocyte: 360 nTPM
- total PBMC: 287 nTPM
Brain region
- cerebral cortex: 13 nTPM
- thalamus: 9 nTPM
- white matter: 8.2 nTPM
- pons: 7.2 nTPM
- amygdala: 6.9 nTPM
- basal ganglia: 6.7 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.63
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.58
- DepMap mean gene effect
- 0.26
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell surface receptor signaling pathway
- positive regulation of phagocytosis
- positive regulation of T cell activation
- signal transduction
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SIRPB1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SIRPB1 as an antibody target. Whether an autoantibody or antibody against SIRPB1 could matter depends on whether native SIRPB1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SIRPB1 is annotated at the cell surface, where native SIRPB1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SIRPB1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...